Metabolic syndrome and the risk of chronic kidney disease

Journal Title: Нирки - Year 2017, Vol 6, Issue 2

Abstract

Metabolic syndrome (MS) is a combination of a disorder of carbohydrate metabolism, abdominal obesity, dyslipidemia and arterial hypertension. Studies show that there is a close relationship between MS and chronic kidney disease (CKD). Patients with MS have a 2.5-fold higher risk of CKD. Factors of CKD development in the metabolic syndrome are an increased level of insulin and insulin resistance, active forms of oxygen, inflammatory mediators, biologically active substan­ces, hormones, inflammatory cytokines, an increase in the activity of coagulation factors, inhibition of the fibrinolytic system. Pathological abnormalities in the kidneys in patients with MS are manifested by microvascular tubular atrophy, interstitial fibrosis and global or segmental sclerosis. Microalbumin is an early marker for MS.

Authors and Affiliations

O. O. Melnyk

Keywords

Related Articles

Ciprofloxacin in Urinary Tract Infection Treatment

Urinary tract infections occupy a leading place among nephrological pathology and infectious diseases in general. The article deals with the aetiology and key stages of the pathogenesis of urinary system lesions. The mai...

Adsorptive-Rheological Properties of Blood Serum in Gouty Nephropathy

The aim and tasks of the study — to evaluate clinical-pathogenetic significance of changes in adsorptive rheological properties of blood serum (ARPB) in patients with different clinical courses of gouty nephropathy. Mate...

Diagnostic Role of N-Acetyl-β-D-Glucosaminidase as an Early Marker of Kidney Damage

In many diseases of the kidneys, N-acetyl-β-D-glucosaminidase (NAG) in the urine is excreted in large quantities. A significant increase in NAG activity is observed at the primary and secondary kidney damage, heavy metal...

Download PDF file
  • EP ID EP208791
  • DOI 10.22141/2307-1257.6.2.2017.102785
  • Views 110
  • Downloads 0

How To Cite

O. O. Melnyk (2017). Metabolic syndrome and the risk of chronic kidney disease. Нирки, 6(2), 80-90. https://www.europub.co.uk/articles/-A-208791